It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Microenvironmental bystander cells are essential for the progression of chronic lymphocytic leukemia (CLL). We have discovered previously that LYN kinase promotes the formation of a microenvironmental niche for CLL. Here we provide mechanistic evidence that LYN regulates the polarization of stromal fibroblasts to support leukemic progression. LYN is overexpressed in fibroblasts of lymph nodes of CLL patients. LYN-deficient stromal cells reduce CLL growth in vivo. LYN-deficient fibroblasts show markedly reduced leukemia feeding capacity in vitro. Multi-omics profiling reveals that LYN regulates the polarization of fibroblasts towards an inflammatory cancer-associated phenotype through modulation of cytokine secretion and extracellular matrix composition. Mechanistically, LYN deletion reduces inflammatory signaling including reduction of c-JUN expression, which in turn augments the expression of Thrombospondin-1, which binds to CD47 thereby impairing CLL viability. Together, our findings suggest that LYN is essential for rewiring fibroblasts towards a leukemia-supportive phenotype.
The survival of chronic lymphocytic leukemia cells strongly depends on the presence of a supportive microenvironment. Here, the authors show that LYN kinase is essential for the reprogramming of stromal cells towards a leukemia-supportive phenotype that facilitates disease progression.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); University of Cologne, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
2 Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); University of Cologne, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); Faculty of Medicine and University Hospital of Cologne, Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany (GRID:grid.411097.a) (ISNI:0000 0000 8852 305X)
3 University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); Faculty of Medicine and University Hospital Cologne, University of Cologne, Institute for Biomedical Informatics, Cologne, Germany (GRID:grid.411097.a) (ISNI:0000 0000 8852 305X)
4 University of Cologne, Center for Molecular Medicine Cologne, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); University of Cologne, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); Faculty of Medicine and University Hospital Cologne, University of Cologne, Institute for Biomedical Informatics, Cologne, Germany (GRID:grid.411097.a) (ISNI:0000 0000 8852 305X)
5 University of Cologne, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
6 University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of General, Visceral and Cancer Surgery, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
7 Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777); Faculty of Medicine and University Hospital of Cologne, Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany (GRID:grid.411097.a) (ISNI:0000 0000 8852 305X); Max-Planck Institute for the Biology of Ageing, Cologne, Germany (GRID:grid.419502.b) (ISNI:0000 0004 0373 6590)
8 Hämatopathologie Lübeck, Reference Centre for Lymph Node Pathology and Hematopathology, Lübeck, Germany (GRID:grid.419502.b); University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Pathology, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
9 University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Pathology, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777)
10 Johann Wolfgang Goethe University, Department of Hematology/Oncology, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); German Cancer Consortium (DKTK), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); Goethe University Frankfurt, Frankfurt Cancer Institute, Frankfurt, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)